J Claude Bennett - Net Worth and Insider Trading
J Claude Bennett Net Worth
The estimated net worth of J Claude Bennett is at least $525,518 dollars as of 2024-09-20. J Claude Bennett is the COO of BioCryst Pharmaceuticals Inc and owns about 65,730 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $525,518. Details can be seen in J Claude Bennett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Claude Bennett has not made any transactions after 2007-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Claude Bennett
J Claude Bennett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Claude Bennett owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of J Claude Bennett’s form 4 insider trades.
Insider Ownership Summary of J Claude Bennett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2007-09-04 | director & President |
J Claude Bennett Latest Holdings Summary
J Claude Bennett currently owns a total of 1 stock. J Claude Bennett owns 65,730 shares of BioCryst Pharmaceuticals Inc (BCRX) as of September 4, 2007, with a value of $525,518.
Latest Holdings of J Claude Bennett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2007-09-04 | 65,730 | 8.00 | 525,518 |
Holding Weightings of J Claude Bennett
J Claude Bennett Form 4 Trading Tracker
According to the SEC Form 4 filings, J Claude Bennett has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 20,000 shares on September 4, 2007, which brought J Claude Bennett around $240,000.
Insider Trading History of J Claude Bennett
- 1
J Claude Bennett Trading Performance
GuruFocus tracks the stock performance after each of J Claude Bennett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Claude Bennett is -39.33%. GuruFocus also compares J Claude Bennett's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Claude Bennett within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Claude Bennett's insider trading performs compared to the benchmark.
Performance of J Claude Bennett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.25 | | | | | |
| Relative Return to S&P 500(%) | -11.92 | | | | | |
J Claude Bennett Ownership Network
J Claude Bennett Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
J Claude Bennett is the director & President of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, J Claude Bennett made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net purchase of 23,000 shares made by Helen M. Thackray , a net sale of 8,689 shares made by Machelle Sanders , and a net sale of 7,866 shares made by Nancy J Hutson .
In summary, during the past 3 months, insiders sold 8,600 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 8,600 shares. During the past 18 months, 43,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 139,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
J Claude Bennett Mailing Address
Above is the net worth, insider trading, and ownership report for J Claude Bennett. You might contact J Claude Bennett via mailing address: C/o Biocryst Pharmaceuticals, Inc, 2190 Pkwy Lake Drive, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
